diabetic gastroparesis

Evoke Pharma finally lands approval for lead and only drug
Endpoints
Mon, 06/22/20 - 11:09 am
Evoke Pharma
FDA
diabetic gastroparesis
diabetes
Gimoti
Allergan’s executive team orchestrates a $200M buyout to beef up gastroenterology pipeline
Endpoints
Thu, 10/27/16 - 09:22 am
Allergan
M&A
relamorelin
diabetic gastroparesis
San Diego biotech files $23M IPO for gastroparesis PhIII
Fierce Biotech
Thu, 05/30/13 - 11:38 am
IPOs
diabetic gastroparesis
Evoke Pharma
Tranzyme stops mid-stage study after drug fails
Yahoo/AP
Mon, 12/17/12 - 12:16 pm
Tranzyme
diabetic gastroparesis
TZP-102